viral
vaccin
vector
shown
effect
induc
robust
immun
respons
vaccin
antigen
newcastl
diseas
viru
ndv
avian
paramyxoviru
promis
vaccin
vector
human
veterinari
pathogen
avirul
ndv
strain
lasota
long
track
record
safeti
efficaci
therefor
use
strain
vaccin
vector
highli
safe
avian
nonavian
speci
ndv
replic
effici
respiratori
track
host
induc
strong
local
system
immun
respons
foreign
antigen
vaccin
vector
ndv
accommod
foreign
sequenc
good
degre
stabil
rna
viru
limit
possibl
recombin
host
cell
dna
use
ndv
vaccin
vector
human
offer
sever
advantag
viral
vaccin
vector
ndv
safe
human
due
host
rang
restrict
preexist
antibodi
ndv
human
popul
ndv
antigen
distinct
common
human
pathogen
ndv
replic
high
titer
cell
line
accept
human
vaccin
develop
therefor
ndv
attract
vaccin
vector
human
pathogen
vaccin
current
avail
ndv
also
attract
vaccin
vector
anim
pathogen
infecti
diseas
emerg
reemerg
millennia
human
immunodefici
viru
hiv
sever
acut
respiratori
syndrom
coronaviru
sarscov
recent
pandem
influenza
viru
mani
exampl
emerg
infecti
pathogen
modern
world
diseas
global
societ
econom
impact
relat
unexpect
ill
death
well
interfer
travel
busi
daili
activ
overcom
emerg
reemerg
well
stabl
infecti
diseas
demand
develop
effici
vaccin
greatli
increas
histor
live
attenu
vaccin
provid
effect
protect
viral
infect
diseas
howev
safeti
concern
risk
revers
wildtyp
pathogen
phenotyp
shown
tradit
live
attenu
vaccin
polio
vaccin
furthermor
develop
live
attenu
vaccin
success
mani
import
pathogen
hand
inactiv
vaccin
gener
effect
requir
high
contain
laboratori
cultiv
highli
virul
pathogen
also
risk
incomplet
inactiv
inactiv
vaccin
therefor
need
altern
approach
develop
vaccin
replic
viral
vector
vaccin
offer
live
vaccin
approach
without
requir
involv
complet
pathogen
cultiv
pathogen
replic
viral
vector
abil
synthes
foreign
antigen
intracellularli
induc
humor
cellular
mucos
immun
respons
specif
vector
vaccin
advantag
virus
live
attenu
vaccin
might
feasibl
ie
hiv
ii
virus
grow
well
vitro
ie
human
papillomaviru
hepat
c
viru
noroviru
iii
highli
pathogen
virus
present
safeti
challeng
vaccin
develop
ie
sarscov
ebola
viru
iv
virus
lose
infect
due
physic
instabl
ie
respiratori
syncyti
viru
rsv
v
virus
exchang
gene
circul
virus
ie
coronavirus
influenza
virus
enterovirus
vector
vaccin
rapidli
engin
newli
emerg
pathogen
viru
insert
gene
protect
antigen
viru
genom
viral
vector
gener
magnitud
immun
respons
live
viral
vector
vaccin
substanti
greater
broader
induc
vaccin
base
subunit
protein
inactiv
virus
furthermor
manufactur
vector
vaccin
highli
pathogen
virus
requir
high
level
biosafeti
contain
laboratori
newcastl
diseas
viru
ndv
fastrepl
avian
viru
preval
speci
bird
avian
speci
ndv
infect
result
diseas
chicken
ndv
caus
highli
contagi
respiratori
neurolog
diseas
lead
sever
econom
loss
poultri
industri
worldwid
ndv
strain
vari
wide
virul
base
sever
diseas
chicken
ndv
strain
classifi
three
pathotyp
lentogen
strain
caus
mild
asymptomat
infect
restrict
respiratori
tract
mesogen
strain
intermedi
virul
velogen
strain
caus
system
infect
high
mortal
natur
occur
lowvirul
ndv
strain
lasota
wide
use
live
attenu
vaccin
control
newcastl
diseas
poultri
although
ndv
primarili
infect
avian
speci
mani
nonavian
speci
also
shown
natur
experiment
suscept
infect
advent
revers
genet
system
manipul
genom
ndv
allow
us
studi
molecular
biolog
pathogenesi
ndv
also
develop
ndv
vaccin
vector
diseas
human
anim
ndv
vector
sever
advantag
replic
viral
vector
avirul
ndv
strain
highli
safe
avian
nonavian
speci
ndv
replic
well
vivo
induc
robust
immun
respons
contrast
adeno
herp
pox
viru
vector
whose
genom
encod
larg
number
protein
ndv
encod
seven
protein
thu
less
competit
immun
respons
vector
protein
express
foreign
antigen
ndv
replic
cytoplasm
integr
host
cell
dna
establish
persist
infect
recombin
involv
ndv
extrem
rare
ndv
modular
genom
facilit
genet
manipul
ndv
infect
via
intranas
rout
therefor
induc
mucos
system
immun
respons
wide
rang
ndv
strain
exist
use
vaccin
vector
ndvvector
vaccin
also
use
differenti
infect
vaccin
anim
diva
vaccin
review
articl
review
biolog
ndv
develop
revers
genet
system
gener
ndvvector
vaccin
use
ndv
vector
develop
human
veterinari
vaccin
ndv
member
genu
avulaviru
famili
paramyxovirida
ndv
virion
pleomorph
mostli
spheric
diamet
nm
virion
envelop
bilay
lipid
membran
genom
ndv
nonseg
negativesens
singlestrand
rna
nucleotid
contain
six
transcript
unit
figur
genom
encod
nucleocapsid
protein
n
phosphoprotein
p
matrix
protein
fusion
protein
f
hemagglutininneuraminidas
protein
hn
larg
polymeras
protein
l
addit
protein
call
v
protein
produc
rna
edit
p
gene
begin
end
gene
contain
control
sequenc
known
genestart
gs
geneend
ge
respect
viral
rnadepend
rna
polymeras
begin
transcript
end
genom
rna
sequenti
manner
stopstart
mechan
reiniti
transcript
gs
perfect
thu
lead
gradient
mrna
abund
high
level
mrna
transcript
virus
locat
end
genom
length
ndv
must
even
multipl
six
effici
viru
replic
follow
rule
six
ndv
hn
f
protein
two
integr
membran
protein
hn
protein
respons
attach
virion
sialic
acid
contain
cell
surfac
receptor
f
protein
mediat
entri
viru
host
cell
fusion
viral
envelop
plasma
membran
f
protein
synthes
precursor
cleav
host
cell
proteas
two
biolog
activ
subunit
cleavag
f
protein
prerequisit
viru
entri
celltocel
fusion
amino
acid
sequenc
f
protein
cleavag
site
identifi
primari
determin
virul
virul
ndv
strain
multibas
residu
conform
prefer
cleavag
site
intracellular
proteas
furin
present
cell
type
contrast
avirul
ndv
strain
typic
contain
one
two
basic
residu
f
protein
cleavag
site
deliv
plasma
membran
uncleav
form
cleavag
extracellular
proteas
thu
restrict
viral
replic
respiratori
enter
tract
secret
proteas
cleavag
avail
infecti
ndv
recov
entir
clone
cdna
transfect
cultur
cell
plasmid
encod
viral
compon
function
nucleocapsid
fulllength
antigenom
rna
major
protein
involv
replic
transcript
ie
n
p
l
protein
control
bacteriophag
rna
polymeras
promot
figur
method
also
known
revers
genet
techniqu
avail
three
pathotyp
ndv
strain
gener
foreign
gene
flank
ndv
gs
ge
sequenc
insert
noncod
region
ndv
genom
addit
transcript
unit
due
polar
gradient
transcript
foreign
gene
express
effici
place
closer
end
genom
although
foreign
gene
place
two
gene
ndv
insert
site
p
gene
found
optim
effici
express
foreign
protein
replic
ndv
insert
foreign
gene
ndv
genom
increas
genom
length
gene
number
often
growth
retard
effect
viru
replic
vitro
vivo
ndv
accommod
foreign
gene
least
kb
length
good
degre
stabil
singl
ndv
vector
also
express
least
three
differ
foreign
gene
ndv
hn
f
protein
two
integr
membran
protein
hn
protein
respons
attach
virion
sialic
acid
contain
cell
surfac
receptor
f
protein
mediat
entri
viru
host
cell
fusion
viral
envelop
plasma
membran
f
protein
synthes
precursor
cleav
host
cell
proteas
two
biolog
activ
subunit
cleavag
f
protein
prerequisit
viru
entri
celltocel
fusion
amino
acid
sequenc
f
protein
cleavag
site
identifi
primari
determin
virul
virul
ndv
strain
multibas
residu
conform
prefer
cleavag
site
intracellular
proteas
furin
present
cell
type
contrast
avirul
ndv
strain
typic
contain
one
two
basic
residu
f
protein
cleavag
site
deliv
plasma
membran
uncleav
form
cleavag
extracellular
proteas
thu
restrict
viral
replic
respiratori
enter
tract
secret
proteas
cleavag
avail
infecti
ndv
recov
entir
clone
cdna
transfect
cultur
cell
plasmid
encod
viral
compon
function
nucleocapsid
fulllength
antigenom
rna
major
protein
involv
replic
transcript
ie
n
p
l
protein
control
bacteriophag
rna
polymeras
promot
figur
method
also
known
revers
genet
techniqu
avail
three
pathotyp
ndv
strain
gener
foreign
gene
flank
ndv
gs
ge
sequenc
insert
noncod
region
ndv
genom
addit
transcript
unit
due
polar
gradient
transcript
foreign
gene
express
effici
place
closer
end
genom
although
foreign
gene
place
two
gene
ndv
insert
site
p
gene
found
optim
effici
express
foreign
protein
replic
ndv
insert
foreign
gene
ndv
genom
increas
genom
length
gene
number
often
growth
retard
effect
viru
replic
vitro
vivo
ndv
accommod
foreign
gene
least
kb
length
good
degre
stabil
singl
ndv
vector
also
express
least
three
differ
foreign
gene
insert
foreign
gene
ndv
genom
increas
genom
length
gene
number
often
growth
retard
effect
viru
replic
vitro
vivo
ndv
accommod
foreign
gene
least
kb
length
good
degre
stabil
singl
ndv
vector
also
express
least
three
differ
foreign
gene
avirul
ndv
strain
lasota
commonli
use
vaccin
vector
proven
track
record
safeti
mesogen
velogen
ndv
strain
use
vaccin
vector
virul
chicken
experiment
studi
mesogen
strain
beaudett
c
bc
evalu
vaccin
vector
nonhuman
primat
strain
bc
replic
higher
titer
induc
substanti
higher
level
antibodi
respons
compar
strain
lasota
indic
would
effect
vaccin
vector
ndv
sever
advantag
use
vaccin
vector
human
ndv
safe
human
due
natur
host
rang
restrict
nonhuman
primat
intranas
intratrach
inocul
african
green
rhesu
monkey
plaqueform
unit
pfu
per
site
ndv
caus
diseas
symptom
replic
restrict
respiratori
tract
human
infect
ndv
appear
limit
benign
base
anecdot
observ
bird
handler
clinic
studi
use
ndv
oncolyt
agent
accord
clinic
studi
ndv
oncolyt
agent
human
intraven
administr
pfu
ndv
human
safe
without
caus
advers
effect
ndv
share
low
level
amino
acid
sequenc
ident
known
human
paramyxovirus
antigen
distinct
common
human
anim
pathogen
thu
would
affect
preexist
immun
human
ndv
infect
via
intranas
rout
shown
induc
humor
cellular
immun
respons
mucos
system
level
murin
nonhuman
primat
model
ndv
strong
stimul
host
immun
respons
thu
provid
adjuv
effect
use
avirul
pathotyp
ndv
human
prevent
possibl
accident
spread
virul
viru
strain
treat
patient
bird
ndv
grow
high
titer
embryon
egg
pfuml
also
vero
cell
pfuml
accept
human
vaccin
develop
fact
ndv
use
express
protect
antigen
variou
human
pathogen
shown
promis
result
nonhuman
primat
ndvvector
vaccin
sever
human
pathogen
discuss
follow
tabl
potenti
recombin
ndv
strain
effect
vaccin
vector
human
first
evalu
express
influenza
viru
hemagglutinin
ha
protein
express
ha
protein
incorpor
virion
appear
cleav
indic
ha
protein
access
proteolyt
enzym
vitro
growth
kinet
pathogen
test
embryon
chicken
egg
indic
attenu
recombin
ndv
intraven
administr
mice
induc
higher
titer
antibodi
influenza
viru
ha
intraperiton
administr
immun
mice
intraven
rout
complet
protect
lethal
dose
influenza
viru
suggest
ndv
safe
effect
vaccin
vector
possibl
use
mammalian
avian
speci
potenti
ndv
vaccin
vector
use
human
first
determin
nonhuman
primat
two
ndv
strain
lasota
bc
evalu
vaccin
vector
nonhuman
primat
insert
hn
protein
human
parainfluenza
viru
type
protect
antigen
two
dose
immun
ndv
strain
confirm
restrict
replic
african
green
monkey
ndvbc
ndvl
rhesu
monkey
ndvbc
howev
serum
antibodi
respons
follow
second
dose
exceed
observ
infect
even
though
replic
much
effici
ndv
anim
first
studi
demonstr
efficaci
ndvvector
vaccin
nonhuman
primat
ebola
viru
ebov
caus
sever
hemorrhag
fever
human
fatal
rate
speci
zair
ebolaviru
infect
individu
due
limit
inactiv
vaccin
viral
vector
base
common
human
pathogen
use
ebov
vaccin
overcom
high
seropreval
vector
base
common
human
pathogen
adult
human
popul
recombin
ndv
strain
lasota
express
ebov
gp
envelop
protein
gener
evalu
potenti
vaccin
ebov
follow
one
intranas
intratrach
inocul
rhesu
monkey
ndvgp
titer
ebovspecif
antibodi
serum
ebovneutr
antibodi
undetect
low
compar
induc
howev
second
immun
result
substanti
boost
serum
immunoglobulin
ig
g
enzymelink
immunosorb
assay
elisa
titer
yet
titer
remain
lower
induc
second
dose
contrast
elisa
iga
titer
respiratori
tract
secret
serum
ebovneutr
antibodi
titer
equal
induc
second
dose
show
efficaci
ndv
vector
compar
vector
primeboost
vaccin
ndv
evalu
vaccin
vector
anoth
import
emerg
pathogen
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
two
ndv
vector
construct
mesogen
strain
bc
ndvbc
lentogen
strain
lasota
f
protein
cleavag
sequenc
modifi
strain
bc
ndvvf
ndv
vector
engin
express
sarscov
spike
glycoprotein
major
protect
antigen
two
dose
immun
african
green
monkey
induc
robust
neutral
antibodi
respons
result
reduct
viru
shed
challeng
sarscov
tissu
cultur
infect
dose
tcid
specif
immun
ndvvf
vector
result
sarscov
titer
reduct
nasal
turbin
trachea
lung
respect
compar
control
anim
ndvbc
vector
even
effect
averag
reduct
viral
titer
nasal
turbin
trachea
lung
respect
studi
demonstr
safeti
protect
efficaci
ndv
topic
respiratori
vaccin
vector
sarscov
use
viral
vector
express
select
hiv
antigen
promis
vaccin
strategi
potenti
ndvvector
vaccin
hiv
infect
first
evalu
gener
recombin
ndv
express
simian
immunodefici
viru
siv
gag
protein
rndvsivgag
vaccin
viru
induc
gagspecif
cellular
immun
respons
mice
among
intraven
intraperiton
intranas
immun
rout
intranas
administr
induc
strongest
protect
immun
respons
surrog
challeng
viru
rvacsivgag
follow
booster
immun
recombin
influenza
virus
express
immunogen
portion
siv
gag
specif
heterolog
vaccin
approach
result
approxim
fold
reduct
rvacsivgag
titer
day
challeng
compar
titer
control
mice
inject
phosphatebuff
salin
pb
magnitud
protect
immun
respons
also
correl
level
cellular
immun
respons
gag
result
suggest
ndv
vector
suitabl
candid
vaccin
hiv
hiv
gag
env
protein
express
ndv
vector
express
level
gag
protein
optim
use
differ
insert
site
ndv
genom
found
codonoptim
gag
insert
p
gene
ndv
induc
highest
level
protein
express
enhanc
immun
respons
hiv
gag
mice
anoth
studi
express
env
protein
ndv
vector
lasota
also
induc
system
mucos
antibodi
respons
guinea
pig
primingboost
intranas
rout
immunogen
intramuscular
rout
coexpress
env
gag
vector
lasota
enhanc
envspecif
gagspecif
immun
respons
guinea
pig
approach
effici
induc
cellular
protect
immun
respons
challeng
vaccinia
virus
express
env
gag
mice
result
suggest
vaccin
singl
ndv
vector
coexpress
env
gag
repres
promis
strategi
enhanc
immunogen
protect
efficaci
hiv
addit
heterolog
prime
ndv
express
boost
purifi
protein
approach
induc
high
neutral
antibodi
titer
guinea
pig
find
suggest
vaccin
multipl
hiv
antigen
combin
broaden
antivir
immun
respons
respiratori
syncyti
viru
rsv
major
caus
sever
lower
respiratori
tract
diseas
infant
elderli
develop
effect
vaccin
rsv
high
prioriti
order
develop
vector
vaccin
rsv
ndv
strain
use
express
fusion
glycoprotein
rsv
ndv
chosen
viral
vector
abil
induc
strong
interferon
ifn
respons
rsv
f
protein
immunogen
present
ndvf
live
rsv
correl
increas
abil
ndv
activ
antigenpres
cell
vitro
induc
high
level
vivo
rsv
fspecif
memori
cell
present
greater
number
ndvfprime
balbc
mice
anim
previous
infect
rsv
consequ
ndv
vaccin
viru
provid
protect
rsv
challeng
studi
also
highlight
adjuv
effect
ndv
vector
mediat
potent
ifn
induct
ndv
also
use
vector
express
immunogen
bacteri
pathogen
lyme
borreliosi
preval
vectorborn
diseas
unit
state
europ
part
asia
ndv
use
express
basic
membran
protein
bmpa
outer
surfac
protein
c
ospc
lyme
diseas
pathogen
borrelia
burgdorferi
balbc
mice
immun
intranas
ndv
vector
mount
vigor
serum
antibodi
respons
ndv
vector
fail
mount
robust
respons
either
intracellular
extracellular
form
bmpa
ospc
contrast
singl
immun
hamster
ndv
vector
via
intranas
intramuscular
intraperiton
rout
result
rapid
rigor
antibodi
respons
bmpa
ospc
challeng
b
burgdorferi
cellsanim
immun
vectorexpress
bmpa
provid
reduct
pathogen
load
joint
studi
show
potenti
ndv
vaccin
vector
bacteri
pathogen
nipah
viru
niv
deadli
emerg
zoonot
pathogen
caus
fatal
enceph
human
pig
glycoprotein
g
fusion
protein
f
two
major
niv
surfac
glycoprotein
stimul
protect
immun
respons
ndv
strain
lasota
express
niv
g
f
protein
rlanivg
rlanivf
respect
evalu
immunogen
mice
pig
follow
second
dose
immun
rlanivg
rlanivf
induc
nivspecif
neutral
antibodi
mice
longlast
neutral
antibodi
pig
least
week
studi
also
show
rlanivg
induc
higher
level
neutral
antibodi
rlanivf
although
protect
efficaci
vaccin
evalu
studi
vaccin
virus
show
potenti
use
protect
human
anim
niv
infect
noroviru
nov
frequent
caus
viral
gastroenter
peopl
age
inabl
nov
grow
cell
cultur
system
greatli
hinder
develop
effect
vaccin
circumv
obstacl
viruslik
particl
vlp
produc
baculoviru
express
system
commonli
use
nov
vaccin
candid
live
vaccin
vector
lasota
modifi
bc
strain
use
express
capsid
protein
nov
strain
norwalk
viru
modifi
bc
vector
multibas
cleavag
site
sequenc
f
gene
chang
strain
lasota
novexpress
protein
form
vlp
cell
cultur
allanto
fluid
embryon
chicken
egg
modifi
bcvector
vaccin
induc
higher
level
serum
cellular
mucos
immun
respons
baculovirusexpress
vlp
mice
result
suggest
ndv
great
potenti
develop
live
nov
vaccin
altern
vlp
produc
larg
quantiti
embryon
egg
cell
cultur
ndv
costeffect
method
produc
vlpbase
vaccin
human
studi
also
implic
develop
ndvvector
vaccin
noncultiv
pathogen
human
ndvvector
vaccin
evalu
sever
anim
speci
ie
chicken
cattl
sheep
cat
mous
pig
dog
veterinari
use
tabl
ndv
natur
vaccin
vector
poultri
pathogen
live
attenu
ndv
vaccin
wide
use
world
therefor
ndv
vector
carri
protect
antigen
anoth
avian
pathogen
use
bival
vaccin
vaccin
econom
poultri
farmer
bival
vaccin
ndv
strain
lasota
first
use
express
hostprotect
immunogen
infecti
bursal
diseas
viru
ibdv
birnaviru
caus
highli
immunosuppress
diseas
chicken
protect
efficaci
lasotaexpress
protein
evalu
challeng
vaccin
chicken
highli
virul
ndv
strain
texa
gb
virul
ibdv
variant
strain
vaccin
provid
protect
ndv
ibdv
booster
immun
induc
higher
level
antibodi
respons
ndv
ibdv
confer
complet
protect
virus
result
indic
recombin
ndv
use
vaccin
vector
avian
pathogen
infecti
laryngotrach
major
respiratori
diseas
chicken
caus
infecti
laryngotrach
viru
iltv
herp
viru
bival
ndvvector
vaccin
iltv
develop
improv
safeti
current
live
attenu
iltv
vaccin
protect
efficaci
ndv
express
three
major
iltv
surfac
glycoprotein
name
gb
gc
gd
evalu
iltv
infect
chicken
particularli
rndvexpress
gd
induc
highest
level
neutral
antibodi
among
test
vaccin
candid
complet
protect
chicken
challeng
virul
iltv
ndv
show
potenti
bival
vaccin
protect
efficaci
rndv
gd
vaccin
attribut
high
level
envelop
incorpor
cell
surfac
express
gd
compar
gb
gc
anoth
studi
lasota
virus
express
gb
gd
iltv
gener
vaccin
chicken
two
virus
confer
protect
virul
iltv
ndv
challeng
addit
lasota
gb
show
protect
commerci
broiler
clinic
diseas
discrep
vaccin
efficaci
two
studi
could
due
differ
level
gb
gd
express
ndv
vector
experiment
condit
infecti
bronchiti
viru
ibv
coronaviru
import
avian
pathogen
caus
respiratori
diseas
broiler
poor
egg
product
breeder
layer
worldwid
spike
polypeptid
gene
express
lasota
vaccin
viru
effect
elicit
hemagglutin
inhibit
antibodi
ndv
protect
chicken
lethal
challeng
virul
strain
ibv
heterotyp
protect
assess
use
primeboost
approach
commerci
avail
attenu
ibv
massachusett
mass
type
vaccin
chicken
prime
ocularli
boost
mass
complet
protect
challeng
virul
arktyp
strain
protect
efficaci
heterolog
vaccin
similar
prime
boost
mass
mass
mass
base
clinic
sign
vaccin
group
appear
equal
protect
challeng
compar
unvaccin
challeng
chicken
shed
challeng
viru
trachea
viral
rna
detect
massvaccin
chicken
chicken
vaccin
mass
mass
unvaccin
challeng
control
show
incid
ibv
rna
detect
respect
result
demonstr
potenti
ndvvector
vaccin
ibv
infect
ndv
vector
also
use
prevent
econom
import
livestock
diseas
rift
valley
fever
viru
rvfv
bunyaviru
caus
recurr
larg
outbreak
human
livestock
ndv
express
rvfv
structur
glycoprotein
gn
gener
ndflgn
immun
calv
via
intranas
rout
elicit
detect
antibodi
respons
wherea
intramuscular
immun
elicit
antibodi
ndv
gn
protein
gener
titer
rvfvneutral
antibodi
modest
vari
improv
efficaci
ndvvector
vaccin
gn
coexpress
anoth
glycoprotein
gc
result
format
vlp
subsequ
releas
produc
cell
homolog
primeboost
vaccin
mice
vaccin
viru
induc
neutral
antibodi
provid
complet
protect
lethal
rvfv
challeng
immunogen
vaccin
viru
evalu
lamb
main
target
speci
rvfv
singl
intramuscular
vaccin
induc
neutral
antibodi
respons
significantli
boost
second
vaccin
although
coexpress
gn
gc
induc
good
immun
respons
protect
efficaci
vaccin
need
evalu
bovin
major
caus
respiratori
tract
diseas
cattl
sinc
modifi
live
vaccin
caus
latent
infect
immun
anim
ndv
express
glycoprotein
gd
gener
vector
vaccin
singl
intranas
intratrach
inocul
calv
ndv
elicit
mucos
system
antibodi
specif
challeng
show
reduc
viru
shed
clinic
sign
immun
calv
compar
unimmun
clave
addit
titer
serum
antibodi
specif
higher
immun
anim
compar
unimmun
anim
indic
vaccin
prime
secondari
respons
indic
ndv
use
vaccin
vector
bovin
gd
may
use
mucos
vaccin
infect
howev
vaccin
might
requir
augment
second
dose
inclus
addit
antigen
rabi
viru
rv
rhabdoviru
caus
fatal
neurolog
diseas
human
anim
gener
effect
safe
afford
rabi
vaccin
ndv
strain
lasota
express
rabi
viru
glycoprotein
g
rlrvg
evalu
safeti
rlrvg
vaccin
viru
confirm
cat
dog
intramuscular
vaccin
rlrvg
induc
strong
longlast
protect
neutral
antibodi
respons
rabi
viru
dog
cat
although
three
dose
vaccin
conduct
second
dose
induc
highest
level
immun
respons
cat
dog
vaccin
dose
embryo
infect
dose
eid
complet
protect
dog
challeng
one
year
studi
demonstr
protect
efficaci
ndvvector
vaccin
rabi
dog
vaccin
may
also
potenti
use
highrisk
human
individu
control
rabi
viru
infect
canin
distemp
viru
cdv
morbilliviru
infect
mani
carnivor
caus
sever
highmort
diseas
outbreak
current
cdv
live
vaccin
safe
use
exot
speci
mink
ferret
ndv
strain
lasota
express
envelop
glycoprotein
hemagglutinin
h
rlacdvh
fusion
protein
f
rlacdvf
gener
vaccin
candid
immun
mink
rlacdvh
induc
higher
titer
neutral
antibodi
cdv
rlacdvf
neutral
antibodi
rlacdvh
provid
complet
protect
virul
cdv
challeng
four
week
observ
contrast
anim
immun
rlacdvf
develop
clinic
sign
distemp
viru
shed
studi
suggest
recombin
ndv
express
h
protein
cdv
safe
effici
candid
vaccin
cdv
mink
efficaci
rlacdvh
viru
also
need
evalu
host
carnivor
speci
highli
pathogen
avian
influenza
viru
hpaiv
econom
import
pathogen
poultri
worldwid
outbreak
involv
influenza
virus
result
lethal
infect
poultri
death
limit
number
peopl
therefor
vaccin
poultri
hpaiv
could
play
import
role
reduc
viru
shed
rais
threshold
infect
transmiss
howev
develop
vaccin
hpaiv
hamper
due
poor
immunogen
viru
furthermor
inactiv
vaccin
commonli
use
high
cost
due
requir
enhanc
biosafeti
level
contain
difficulti
differenti
infect
vaccin
anim
diva
use
live
attenu
influenza
virus
vaccin
avian
mammalian
speci
also
rais
major
biosafeti
concern
vaccin
virus
may
becom
virul
mutat
genet
reassort
circul
strain
altern
ndv
ideal
vaccin
vector
develop
avian
influenza
vaccin
ndv
infect
via
intranas
rout
therefor
induc
local
system
immun
respons
respiratori
tract
therefor
provid
conveni
platform
rapid
effici
econom
immun
fact
ndv
commonli
use
vaccin
vector
aiv
protect
efficaci
ndvvector
vaccin
evalu
verifi
mani
differ
vaccin
studi
gener
vaccin
major
protect
antigen
hemagglutinin
ha
hpaiv
place
p
gene
f
hn
gene
lentogen
ndv
strain
lasota
address
safeti
concern
ndvvector
vaccin
gener
replac
polybas
cleavag
site
hpaiv
ha
lowpathogen
strain
influenza
viru
addit
ha
gene
modifi
enhanc
express
level
ndv
specif
elimin
ndv
transcript
termin
signallik
sequenc
locat
within
ha
open
read
frame
enhanc
express
level
ha
protein
ndv
complet
protect
chicken
challeng
lethal
dose
velogen
ndv
highli
pathogen
aiv
respect
addit
ectodomain
avian
influenza
viru
ha
fuse
transmembran
cytoplasm
domain
deriv
f
protein
ndv
approach
result
enhanc
incorpor
foreign
protein
viru
particl
protect
chicken
hpaiv
highli
virul
ndv
studi
also
demonstr
ndv
use
gener
bival
vaccin
although
use
avirul
ndv
vector
effect
protect
chicken
clinic
diseas
mortal
studi
also
found
viru
shed
chicken
challeng
hpaiv
enhanc
replic
vaccin
viru
attenu
mesogen
ndv
strain
bc
gener
chang
multibas
cleavag
site
sequenc
f
protein
dibas
sequenc
strain
lasota
addit
bc
f
hn
protein
modifi
sever
way
enhanc
viru
replic
modifi
bcbase
vector
replic
better
lasota
vector
express
higher
level
ha
protein
provid
complet
protect
challeng
viru
shed
suggest
potenti
safe
use
vaccin
vector
effect
human
vaccin
hpaiv
immunogen
ndv
express
ha
evalu
african
green
monkey
intranas
rout
administr
two
dose
ndvvector
vaccin
pfu
induc
high
titer
hpaivneutr
serum
antibodi
immun
monkey
moreov
substanti
mucos
iga
respons
induc
respiratori
tract
potenti
reduc
prevent
transmiss
viru
outbreak
pandem
intranas
rout
administr
also
advantag
needlefre
immun
thu
suitabl
mass
immun
protect
efficaci
vaccin
virus
evalu
african
green
monkey
intranasalintratrach
rout
aerosol
rout
administr
vaccin
construct
highli
restrict
replic
low
level
viru
shed
detect
respiratori
secret
group
develop
high
level
neutral
antibodi
homolog
heterolog
strain
hpaiv
protect
challeng
pfu
homolog
hpaiv
studi
demonstr
needlefre
highli
attenu
ndvvector
vaccin
immunogen
protect
nonhuman
primat
model
hpaiv
infect
newcastl
diseas
viru
ndv
attract
vaccin
vector
human
anim
pathogen
live
attenu
vaccin
strain
use
vaccin
vector
proven
track
record
safeti
efficaci
ndv
vector
induc
robust
humor
cellular
immun
respons
also
induc
mucos
immun
respons
therefor
ndv
vector
choic
mucos
immun
abil
ndv
infect
wide
varieti
nonavian
speci
make
potenti
vector
anim
ndv
also
promis
vaccin
vector
use
human
one
advantag
human
preexist
immun
ndv
ndvvector
vaccin
also
becom
avail
commerci
ie
hpaiv
vaccin
poultri
